Impulsive and compulsive behaviors in Parkinson's disease: A one-year follow-up study


      Impulsive and compulsive behaviors (ICBs) have been reported to occur frequently in Parkinson's disease (PD) and include impulse control disorders (ICDs), punding and dopamine dysregulation syndrome (SSD). We report on the outcomes of 25 PD patients who developed ICBs. Information was collected on changes in parkinsonian and psychiatric medication follow-up (median=12.1 months). At time 1, only 18 patients (72%) were taking dopamine agonists (DA). At time 2, fifteen patients (83.33%) either discontinued or decreased their DA treatment. Of these patients, thirteen (86.67%) reported experiencing full or partial remission of their ICBs symptoms. When analyzing separately the 11 patients with punding, these symptoms remained unchanged in 9 patients (81.82%) independently of changes in dopaminergic drugs. In conclusion, the current study suggests that there are clear similarities, but also important differences, between punding and ICDs over time. Pathological gambling, binge or compulsive eating, pathological hypersexuality and compulsive shopping in PD were robustly associated with the use of DA but the relationship between dopaminergic medications and punding is less clear. It is important to determine if other treatment strategies may be effective for punding in PD.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Voon V.
        • Hassan K.
        • Zurowski M.
        • de Souza M.
        • Thomsen T.
        • Fox S.
        • et al.
        Prevalence of repetitive and reward-seeking behaviors in Parkinson's disease.
        Neurology. 2006; 67: 1254-1257
        • Mamikonyan E.
        • Siderowf A.D.
        • Duda J.E.
        • Potenza M.N.
        • Horn S.
        • Stern M.B.
        • et al.
        Long-term follow-up of impulse control disorders in Parkinson's disease.
        Mov Disord. 2008; 23: 75-80
        • Evans A.H.
        • Strafella A.P.
        • Weintraub D.
        • Stacy M.
        Impulsive and compulsive behaviors in Parkinson's disease.
        Mov Disord. 2009; 24: 1561-1570
        • Wu K.
        • Politis M.
        • Piccini P.
        Parkinson's disease and impulse control disorders: a review of clinical features, pathophysiology and management.
        Postgrad Med J. 2009; 85: 590-596
        • Weintraub D.
        • Koester J.
        • Potenza M.N.
        • Siderowf A.D.
        • Stacy M.
        • Voon V.
        • et al.
        Impulse control disorders in Parkinson disease. A cross-sectional study of 3090 patients.
        Arch Neurol. 2010; 67: 589-595
        • Evans A.H.
        • Katzenschlager R.
        • Paviour D.
        • O'Sullivan J.D.
        • Appel S.
        • Lawrence A.D.
        • et al.
        Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.
        Mov Disord. 2004; 19: 397-405
        • Evans A.H.
        • Lawrence A.D.
        • Potts J.
        • Appel S.
        • Lees A.J.
        Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease.
        Neurology. 2005; 65: 1570-1574
        • Klos K.J.
        • Bower J.H.
        • Josephs K.A.
        • Matsumoto J.Y.
        • Ahlskog J.E.
        Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
        Parkinsonism Relat Disord. 2005; 11: 381-386
        • Pontone G.
        • Williams J.R.
        • Basset S.S.
        • Marsh L.
        Clinical features associated with impulse control disorders in Parkinson's disease.
        Neurology. 2006; 67: 1258-1261
        • Voon V.
        • Thomsen T.
        • Miyasaki J.N.
        • de Souza M.
        • Shafro A.
        • Fox S.H.
        • et al.
        Factors associated with dopaminergic drug-related pathological gambling in Parkinson' disease.
        Arch Neurol. 2007; 64: 212-216
        • Giladi N.
        • Weitzman N.
        • Schreiber S.
        • Shatai H.
        • Peretz C.
        New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
        J Psychopharmacol. 2007; 21: 501-506
        • Voon V.
        • Fox S.H.
        Medication-related impulse control and repetitive behaviors in Parkinson'disease.
        Arch Neurol. 2007; 64: 1089-1096
        • Lawrence A.J.
        • Blackwell A.D.
        • Barker R.A.
        • Spagnolo F.
        • DPhil L.C.
        • Aitken M.R.F.
        • et al.
        Predictors of punding in Parkinson's disease: results from a questionnaire survey.
        Mov Disord. 2007; 22: 2339-2345
        • Avila A.
        • Cardona X.
        • Bello J.
        • Maho P.
        • Sastre F.
        • Martin-Baranera M.
        Impulse control disorders and punding in Parkinson's disease : the need for a structured interview.
        Neurologia. 2011; 26: 166-172
        • Fahn S.
        • Elton R.L.
        • the UPDRS Development Committee
        Unified Parkinson's disease rating scale.
        in: Fahn S. MArsden C.D. Calne D. Goldstein M. Recent Developments in Parkinson's Disease. Macmillan Health Care Information, Florham Park, NJ1987: 153-163
        • Hoehn M.M.
        • Yahr M.D.
        Parkinsonism: onset, progression, and mortality.
        Neurology. 1967; 17: 427-442
        • Cervantes-Arriaga A.
        • Rodríguez-Violante M.
        • Villar-Velarde A.
        • Corona T.
        Cálculo de unidades de equivalencia de levodopa en enfermedad de Parkinson.
        Arch Neurocien (Mex). 2009; 14: 116-119
        • Weintraub D.
        • Siderowf A.D.
        • Potenza M.N.
        • Goveas J.
        • Morales K.H.
        • Duda J.E.
        • et al.
        Association of dopamine agonist use with impulse control disorders in Parkinson's disease.
        Arch Neurol. 2006; 63: 969-973
        • Siri C.
        • Antonini A.
        • Santangelo G.
        • Cilia R.
        • Poletti M.
        • Canesi M.
        • et al.
        Frequency of impulse control disorders in “de novo” patients with Parkinson's disease: a follow up study after one year of dopamine replacement therapy.
        in: 7th Internacional Congress on Mental Dysfunction & Other Non-Motor Features in Parkinson's disease & Related Didorders. Barcelona, Spain. Dec. 9–12, 2010
        • Driver-Dunckley E.
        • Samanta J.
        • Stacy M.
        Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.
        Neurology. 2003; 61: 422-423
        • Grosset K.A.
        • Macphee G.
        • Pal G.
        • Stewart D.
        • Watt A.
        • Davie J.
        • et al.
        Problematic gambling on dopamine agonists: not such a rarity.
        Mov Disord. 2006; 21: 2206-2208
        • Nirenberg M.J.
        • Waters C.
        Compulsive eating and weight gain related to dopamine agonist use.
        Mov Disord. 2006; 21: 524-529
        • Weintraub D.
        Dopamine and impulse control disorders in Parkinson's disease.
        Ann Neurol. 2008; 64 (suppl): S93-S100
        • Miyasaki J.N.
        • Hassan K.L.
        • Lang A.E.
        • Voon V.
        Punding prevalence in Parkinson's disease.
        Mov Disord. 2007; 22: 1179-1181
        • Spencer A.H.
        • Rickarards H.
        • Fasano A.
        • Cavanna A.E.
        The prevalence and clinical characteristics of punding in Parkinson's disease.
        Mov Disord. 2011; 26: 578-586